We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$29.4B
AUM Growth
-$873M
Cap. Flow
+$534M
Cap. Flow %
1.81%
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$244M
2
ENPH icon
Enphase Energy
ENPH
+$229M
3
GSK icon
GSK
GSK
+$223M
4
ACN icon
Accenture
ACN
+$209M
5
C icon
Citigroup
C
+$209M

Sector Composition

Rank Sector Weight
1 Technology 21.52%
2 Healthcare 13.7%
3 Financials 9.76%
4 Industrials 8.72%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFBK
2676
DELISTED
Northfield Bancorp
NFBK
-27,070
Closed -$353K
NGD
2677
DELISTED
New Gold Inc
NGD
-1,875,833
Closed -$2.01M
NKSH icon
2678
National Bankshares
NKSH
$262M
-6,443
Closed -$202K
NMIH icon
2679
NMI Holdings
NMIH
$3.4B
-96,386
Closed -$1.6M
NMRK icon
2680
Newmark Group
NMRK
$2.94B
-53,741
Closed -$520K
NN icon
2681
NextNav
NN
$2.96B
-187,361
Closed -$425K
NPK icon
2682
National Presto Industries
NPK
$1.07B
-14,690
Closed -$964K
NRXP icon
2683
NRX Pharmaceuticals
NRXP
$154M
-4,145
Closed -$25K
NTR icon
2684
Nutrien
NTR
$35.9B
-398,429
Closed -$31.8M
NVEC icon
2685
NVE Corp
NVEC
$532M
-6,658
Closed -$310K
NVEE
2686
DELISTED
NV5 Global
NVEE
-21,200
Closed -$619K
NVMI
2687
Nova
NVMI
$12B
-11,036
Closed -$977K
NVO
2688
Novo Nordisk
NVO
$207B
-256,334
Closed -$14.3M
NVTS icon
2689
Navitas Semiconductor
NVTS
$3.39B
-250,495
Closed -$967K
NWBI icon
2690
Northwest Bancshares
NWBI
$2.26B
-119,255
Closed -$1.53M
OGI
2691
Organigram Holdings
OGI
$176M
-19,897
Closed -$73K
OM icon
2692
Outset Medical
OM
$79.1M
-9,229
Closed -$2.06M
SVRN
2693
OceanPal Inc
SVRN
$14.9M
0
-$6K
OPY icon
2694
Oppenheimer Holdings
OPY
$1.24B
-8,300
Closed -$274K
OVV icon
2695
Ovintiv
OVV
$18.5B
-52,087
Closed -$2.3M
OXM icon
2696
Oxford Industries
OXM
$540M
-3,771
Closed -$335K
OXY icon
2697
Occidental Petroleum
OXY
$61.3B
-1,223,362
Closed -$72M
PACB icon
2698
Pacific Biosciences
PACB
$420M
-4,487,462
Closed -$19.8M
PAGS icon
2699
PagSeguro Digital
PAGS
$2.38B
-323,463
Closed -$3.31M
PBI icon
2700
Pitney Bowes
PBI
$2.26B
-97,891
Closed -$354K

Similar funds

John Overdeck's Q3 2022 Portfolio in Review

As of Q3 2022, John Overdeck held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

John Overdeck's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • John Overdeck's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
  • John Overdeck added most to GSK in Q3 2022, an estimated $223M increase.
  • John Overdeck's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
  • John Overdeck fully exited Bank of America in Q3 2022, selling an estimated $225M.
  • John Overdeck's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
  • John Overdeck opened 582 new positions and closed 600 in Q3 2022.
  • John Overdeck's portfolio value fell 2.9% quarter-over-quarter to $29.4B.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.